The former could cause white matter neurodegeneration and worsen AD pathology (β-amyloid and tau), while the latter could impede vascular clearance path through the BBB and glymphatic system; furthermore, aggregated neurotoxic peptides lead to ischemic neuronal death [15, 53, 54]. The gene discussed is MAPT; the disease is Alzheimer disease.